2019
DOI: 10.1016/j.kint.2019.04.039
|View full text |Cite
|
Sign up to set email alerts
|

Group 1 innate lymphoid cells are involved in the progression of experimental anti-glomerular basement membrane glomerulonephritis and are regulated by peroxisome proliferator-activated receptor α

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 68 publications
0
8
0
Order By: Relevance
“…Bernink et al (2013) revealed that the frequency of circulating ILC1s was elevated in intestinal injury and ILC1-derived IFN-γ exaggerated inflammation. Furthermore, Okabayashi et al (2019) reported that treatment with ILC1-targeted receptor agonist attenuated renal injury by downregulating T-bet mRNAs expression and reducing IFN-γ production. Through IFN-γ secretion, ILC1s can aid Th1 cell priming and modulate Th1 immune response directly or indirectly (Sonnenberg and Hepworth, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Bernink et al (2013) revealed that the frequency of circulating ILC1s was elevated in intestinal injury and ILC1-derived IFN-γ exaggerated inflammation. Furthermore, Okabayashi et al (2019) reported that treatment with ILC1-targeted receptor agonist attenuated renal injury by downregulating T-bet mRNAs expression and reducing IFN-γ production. Through IFN-γ secretion, ILC1s can aid Th1 cell priming and modulate Th1 immune response directly or indirectly (Sonnenberg and Hepworth, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Anti-GBM glomerulonephritis was induced in Wistar-Kyoto rats (Charles River Japan, Kanagawa, Japan) by a single intravenous injection of rabbit anti-rat GBM antibodies (50 µg IgG/100 g body weight) as described previously 3,4,8,22 . To evaluate the effects of DSF (NOCBIN, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan), the rats were orally administered DSF (50 or 100 mg/kg/day) or vehicle (0.5% w/v carboxymethyl cellulose) once daily, initiated on the day before injecting the anti-GBM antibody.…”
Section: Induction Of Anti-gbm Glomerulonephritis In Ratsmentioning
confidence: 99%
“…While in the MRL-lpr model the other helper ILC subsets were unaltered (20), a recent study suggested that a previously unknown ILC1 subtype expressing CD8 might infiltrate glomeruli in rat and potentially also in human anti-GBM nephritis (49). However, if this CD8 + cell subset indeed FIGURE 2 | Protective role of ILC2s in chronic kidney diseases.…”
Section: Ilcs In Glomerulonephritismentioning
confidence: 97%